Table 1.
Demographics and Clinical Factors of Patients With Chronic Hepatitis C Invited to Participate in the 2017‐2018 Survey, According to Response (CHeCS)
| Variables | N (%) | Responded n (%) | Did Not Respond n (%) | P Value |
|---|---|---|---|---|
| Total | 2,681 | 1,051 (39.2) | 1,630 (60.8) | − |
| Sex | ||||
| Male | 1,614 (60.2) | 608 (57.8) | 1,006 (61.7) | |
| Female | 1,067 (39.8) | 443 (42.2) | 624 (38.3) | 0.048 |
| Race | ||||
| Non‐Hispanic White | 1,498 (55.9) | 654 (62.2) | 844 (51.8) | |
| Non‐Hispanic Black | 942 (35.1) | 311 (29.6) | 631 (38.7) | |
| Other | 241 (9.0) | 86 (8.2) | 155 (9.5) | <0.001 |
| Age (years) on Jan 1, 2017 | ||||
| ≤30 | 60 (2.2) | 17 (1.6) | 43 (2.6) | |
| 31‐40 | 106 (4.0) | 32 (3.0) | 74 (4.5) | |
| 41‐50 | 130 (4.8) | 45 (4.3) | 85 (5.2) | |
| 51‐60 | 665 (24.8) | 276 (26.3) | 389 (23.9) | |
| 61‐70 | 1,469 (54.8) | 601 (57.2) | 868 (53.3) | |
| >70 | 251 (9.4) | 80 (7.6) | 171 (10.5) | 0.005 |
| Insurance status (6 missing) | ||||
| None | 95 (3.6) | 23 (2.2) | 72 (4.4) | |
| Private | 1,110 (41.5) | 385 (36.6) | 725 (44.6) | |
| Medicaid | 376 (14.1) | 175 (16.7) | 201 (12.4) | |
| Medicare | 911 (34.1) | 287 (27.3) | 624 (38.4) | |
| Medicare + supplement | 183 (6.8) | 181 (17.2) | 2 (0.1) | <0.001 |
| Annual income (88 missing) | ||||
| <$30K | 701 (27.0) | 245 (24.0) | 456 (29.0) | |
| $30‐<50K | 1,065 (41.1) | 424 (41.5) | 641 (40.8) | |
| ≥$50K | 827 (31.9) | 352 (34.5) | 475 (30.2) | 0.009 |
| Study Site | ||||
| Portland, OR | 274 (10.2) | 141 (13.4) | 133 (8.2) | |
| Honolulu, HI | 149 (5.6) | 70 (6.7) | 79 (4.8) | |
| Detroit, MI | 1,645 (61.4) | 579 (55.1) | 1,066 (65.4) | |
| Danville, PA | 613 (22.9) | 261 (24.8) | 352 (21.6) | <0.001 |
| Genotype (412 missing) | ||||
| Genotype 1 | 1,859 (81.9) | 771 (82.8) | 1,088 (81.3) | |
| Genotype 2 | 199 (8.8) | 82 (8.8) | 117 (8.7) | |
| Genotype 3 | 159 (7.0) | 59 (6.3) | 100 (7.5) | |
| Genotype 4‐6 | 45 (2.0) | 16 (1.7) | 29 (2.2) | |
| Genotype mixed | 7 (0.3) | 3 (0.3) | 4 (0.3) | 0.780 |
| Cirrhosis status | ||||
| Decompensated | 321 (12.0) | 142 (13.5) | 179 (11.0) | |
| Compensated | 734 (27.4) | 288 (27.4) | 446 (27.4) | |
| None | 1,626 (60.6) | 621 (59.1) | 1,005 (61.7) | 0.128 |
| Charlson comorbidity score | ||||
| 0 | 1,730 (64.5) | 639 (60.8) | 1,091 (66.9) | |
| 1 | 363 (13.5) | 168 (16.0) | 195 (12.0) | |
| 2+ | 588 (21.9) | 244 (23.2) | 344 (21.1) | 0.002 |
| Mean years (SE) CHeCS follow‐up | 9.71 (0.11) | 9.62 (0.18) | 9.77 (0.14) | 0.340 |